You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Extended release injectable Naltrexone

Showing 1 - 25 of 8,097
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cocaine Use Disorder Trial (Extended-Release Naltrexone, Extended Release Buprenorphine, Placebo (PLB) Injectable)

Not yet recruiting
  • Cocaine Use Disorder
  • Extended-Release Naltrexone
  • +2 more
  • (no location specified)
Jul 15, 2022

Opioid-use Disorder, Opioid Withdrawal Trial in Rancho Mirage, Baltimore, Center City (Sparrow Ascent Therapy System,

Recruiting
  • Opioid-use Disorder
  • Opioid Withdrawal
  • Sparrow Ascent Therapy System
  • +2 more
  • Rancho Mirage, California
  • +2 more
Jun 9, 2022

Alcohol Use Disorder, Alcoholism Trial in Philadelphia (XR-NTX 380 mg, intramuscular injection, Medical Management, Placebo

Recruiting
  • Alcohol Use Disorder
  • Alcoholism
  • XR-NTX 380 mg, intramuscular injection
  • +2 more
  • Philadelphia, Pennsylvania
    University of Pennsylvania Center for Studies of Addiction
Jun 6, 2022

Cocaine Dependence Trial in United States (Buprenorphine + Naltrexone, Placebo + Naltrexone)

Completed
Has Results
  • Cocaine Dependence
  • Buprenorphine + Naltrexone
  • Placebo + Naltrexone
  • Los Angeles, California
  • +10 more
Oct 1, 2021

Opiate Dependence Trial in Philadelphia (extended release naltrexone)

Completed
Has Results
  • Opiate Dependence
  • extended release naltrexone
  • Philadelphia, Pennsylvania
    Center on the Studies of Addiction
Jan 12, 2021

Heavy Drinking, Alcohol Dependence, Alcohol Use Disorder Trial in Boston (Oral naltrexone (PO-NTX), Extended-release injectable

Completed
Has Results
  • Heavy Drinking
  • +2 more
  • Oral naltrexone (PO-NTX)
  • Extended-release injectable naltrexone (XR-NTX)
  • Boston, Massachusetts
    Boston Medical Center
Jun 9, 2021

Heroin Dependence, Opioid Dependence Trial in Philadelphia (Naltrexone)

Completed
  • Heroin Dependence
  • Opioid Dependence
  • Philadelphia, Pennsylvania
    Center for the Studies of Addiction
Feb 11, 2022

Alcohol Use Disorder Trial (injectable naltrexone, oral naltrexone)

Not yet recruiting
  • Alcohol Use Disorder
  • injectable naltrexone
  • oral naltrexone
  • (no location specified)
Feb 23, 2022

Opiate Dependence, Human Immunodeficiency Virus Trial in Moscow (injectable naltrexone, comparator)

Completed
  • Opiate Dependence
  • Human Immunodeficiency Virus
  • injectable naltrexone
  • placebo comparator
  • Moscow, Russian Federation
    Federal Medical Research Center for Psychiatry and Narcology (FM
Nov 5, 2020

Opioid-use Disorder Trial in Loerenskog (Extended release naltrexone)

Completed
  • Opioid-use Disorder
  • Extended release naltrexone
  • Loerenskog, Akershus, Norway
    Akershus University Hospital
Nov 30, 2022

Drug Dependence Trial in Baltimore (Extended Release Naltrexone, Psychosocial Treatment, Buprenorphine)

Completed
Has Results
  • Drug Dependence
  • Extended Release Naltrexone
  • +2 more
  • Baltimore, Maryland
  • +1 more
Oct 13, 2021

Opioid-Use Disorder, Opioid Overdose Trial in Vancouver

Recruiting
  • Opioid-Use Disorder
  • Opioid Overdose
    • Vancouver, British Columbia, Canada
      Rapid Access Addiction Clinic (RAAC), St. Paul's Hospital
    Nov 16, 2022

    Cannabis Use Disorder Trial in Toronto (Naltrexone 380 MG [Vivitrol], Motivational Enhancement Therapy and Cognitive Behavioral

    Not yet recruiting
    • Cannabis Use Disorder
    • Naltrexone 380 MG [Vivitrol]
    • Motivational Enhancement Therapy and Cognitive Behavioral Therapy
    • Toronto, Ontario, Canada
      Centre for Addiction and Mental Health
    Sep 24, 2020

    Obesity Trial (Naltrexone-Bupropion (NB) Combination, Placebo)

    Not yet recruiting
    • Obesity
    • Naltrexone-Bupropion (NB) Combination
    • Placebo
    • (no location specified)
    Oct 18, 2023

    Alcohol Use Disorder, Substance Use, Alcohol Abuse or Dependence Trial in San Francisco (Vivitrol (Extended Release Naltrexone))

    Completed
    • Alcohol Use Disorder
    • +2 more
    • Vivitrol (Extended Release Naltrexone)
    • San Francisco, California
      University of California, San Francisco
    Aug 3, 2022

    Human Immunodeficiency Virus, Opioid Use Disorder Trial in Providence (Combined LAI Treatment: Cabenuva and Sublocade)

    Recruiting
    • Human Immunodeficiency Virus
    • Opioid Use Disorder
    • Combined LAI Treatment: Cabenuva and Sublocade
    • Providence, Rhode Island
      Rhode Island Hospital
    Aug 7, 2023

    Opioid-use Disorder Trial in Baltimore (XR-B, XR-NTX)

    Recruiting
    • Opioid-use Disorder
    • Baltimore, Maryland
      Friends Research Institute
    Aug 18, 2021

    Opiate Withdrawal Syndrome, Opioid Use Trial in Philadelphia (LFX/PGB, LFX/PLA-PGB)

    Not yet recruiting
    • Opiate Withdrawal Syndrome
    • Opioid Use
    • Philadelphia, Pennsylvania
      University of Pennsylvania, Treatment Research Center
    Aug 18, 2023

    Alcohol Dependence, Alcohol Use Disorder Trial in New York (XR-NTX+CM (Extended-Release Naltrexone plus Care Management))

    Completed
    Has Results
    • Alcohol Dependence
    • Alcohol Use Disorder
    • XR-NTX+CM (Extended-Release Naltrexone plus Care Management)
    • New York, New York
      Bellevue Hospital Center
    Apr 18, 2022

    Opioid-Related Disorders Trial in Raleigh (Naltrexone for extended-release injectable suspension, Oral naltrexone)

    Completed
    Has Results
    • Opioid-Related Disorders
    • Naltrexone for extended-release injectable suspension
    • Oral naltrexone
    • Raleigh, North Carolina
      Fellowship Health Resources (FHR)
    Jun 12, 2020

    Opioid Use Disorder (OUD) Trial in United States (SL-BUP, XR-BUP, XR-NTX)

    Recruiting
    • Opioid Use Disorder (OUD)
    • Little Rock, Arkansas
    • +18 more
    Jun 8, 2022

    Opioid-Related Disorders, Substance-Related Disorders, Narcotic-Related Disorders Trial in United States (Injectable

    Not yet recruiting
    • Opioid-Related Disorders
    • +2 more
    • Injectable extended-release buprenorphine
    • Sublingual buprenorphine-naloxone
    • Garberville, California
    • +5 more
    Aug 28, 2023

    Opioid Dependence Trial (Brixadi, Vivitrol)

    Not yet recruiting
    • Opioid Dependence
    • (no location specified)
    Feb 11, 2022

    Opioid Use Disorder Trial in Philadelphia (Buprenorphine injection, Naltrexone Injection)

    Recruiting
    • Opioid Use Disorder
    • Buprenorphine injection
    • Naltrexone Injection
    • Philadelphia, Pennsylvania
      Addiction Treatment Center, University of Pennsylvania
    Feb 1, 2023

    Opiate Substitution Treatment Trial in United Kingdom (Buprenorphine Injectable Product, Methadone, Buprenorphine)

    Active, not recruiting
    • Opiate Substitution Treatment
    • Buprenorphine Injectable Product
    • +2 more
    • Birmingham, United Kingdom
    • +4 more
    Feb 21, 2022